People · Operator
Named in public records as an officer, director or promoter · active 2022–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Zenas BioPharma, Inc. | — | Biotechnology | Series D+ | $384.0M | $2.3B | 2022 |
JOHN JACOB ORLOFF at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside JOHN JACOB ORLOFF on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Leon O. Moulder, Jr. | 1 | 6 |
| PATRICK GERALD ENRIGHT | 1 | 1 |
| TOMAS O. KISELAK | 1 | 1 |
| PATRICIA JACOB ALLEN | 1 | 1 |
| JOSEPH O. FARMER | 1 | 1 |
| JAKE JACOB NUNN | 1 | 1 |
| TIM JACOB XIAO | 1 | 1 |
| JENNIFER JACOB FOX | 1 | 1 |
| JAMES PATRICK BOYLAN | 1 | 1 |
| TANYA Z. FISCHER | 1 | 1 |
| HONGBO O. LU | 1 | 1 |
| HUA O. MU | 1 | 1 |
| MARIETTA O. WU | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.